Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., MD (Medicine), FACP (USA)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Gastroenterologist
MBBS, FCPS Gastroenterology
Gastroenterologist
MBBS, FCPS Gastroenterology
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRACP (Australia)
Family Physician
M.B.B.S, M.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures